RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
13.18
-0.10 (-0.75%)
Sep 9, 2025, 10:23 AM - Market open
RAPT Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$33.60
Upside
+154.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | -31.71% | Aug 12, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $51 → $38 | Buy | Maintains | $51 → $38 | +188.32% | Aug 8, 2025 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $14 | Sell → Hold | Upgrades | $14 | +6.22% | Jul 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $27 | Strong Buy | Maintains | $6 → $27 | +104.86% | Jul 10, 2025 |
| UBS | UBS | Hold Maintains $16 → $8 | Hold | Maintains | $16 → $8 | -39.30% | May 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +264.19% | May 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +506.98% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $80 | Hold → Strong Buy | Upgrades | $80 | +506.98% | Dec 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 25, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $136 → $32 | Buy | Maintains | $136 → $32 | +142.79% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 12, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Nov 11, 2024 |
| UBS | UBS | Hold Maintains $80 → $16 | Hold | Maintains | $80 → $16 | +21.40% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 23, 2024 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.